Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial

The purpose of this phase III clinical trial was to compare two different extracellular contrast agents, 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine, for magnetic resonance imaging (MRI) in patients with known or suspected focal renal lesions. Using a multicenter, single-blind, interindividua...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European radiology 2008-11, Vol.18 (11), p.2610-2619
Hauptverfasser:	Tombach, Bernd, Bohndorf, Klaus, Brodtrager, Wolfgang, Claussen, Claus D., Düber, Christoph, Galanski, Michael, Grabbe, Eckhardt, Gortenuti, Giacomo, Kuhn, Michael, Gross-Fengels, Walter, Hammerstingl, Renate, Happel, Brigitte, Heinz-Peer, Gertraud, Jung, Gregor, Kittner, Thomas, Lagalla, Roberto, Lengsfeld, Philipp, Loose, Reinhard, Oyen, Raymond H. G., Pavlica, Pietro, Pering, Christiane, Pozzi-Mucelli, Roberto, Persigehl, Thorsten, Reimer, Peter, Renken, Nomdo S., Richter, Götz M., Rummeny, Ernst J., Schäfer, Fritz, Szczerbo-Trojanowska, Malgorzata, Urbanik, Andrzej, Vogl, Thomas J., Hajek, Paul
Format:	Artikel
Sprache:	eng
Schlagworte:	Contrast Media Diagnostic Radiology Europe - epidemiology Female Gadolinium DTPA - administration & dosage Humans Image Enhancement - methods Imaging Internal Medicine Interventional Radiology Kidney Neoplasms - diagnosis Kidney Neoplasms - epidemiology Magnetic Resonance Magnetic Resonance Imaging - methods Male Medicine Medicine & Public Health Middle Aged Neuroradiology Organometallic Compounds - administration & dosage Radiology Reproducibility of Results Sensitivity and Specificity Single-Blind Method Ultrasound
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!